Monday, November 6, 2017

Pharma Reviews: GST on expired and damaged stocks costs pharma Rs 500 crore a year

Why should there be the Goods and Services Tax (GST) on materials that cannot be sold? That is the question, the Indian pharmaceutical industry, ...
Read more: GST on expired and damaged stocks costs pharma Rs 500 crore a year